Evelo Biosciences Granted U.S. Patent #11672834 For "PREBIOTIC COMPOSITIONS AND METHODS OF USE THEREOF FOR MODULATION OF THE MICROBIOME"
Portfolio Pulse from Happy Mohamed
Evelo Biosciences has been granted U.S. Patent #11672834 for prebiotic compositions and methods of use for modulation of the microbiome. This patent strengthens the company's intellectual property portfolio.
June 15, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evelo Biosciences' new patent for prebiotic compositions may lead to increased investor interest and potential growth in the company's product pipeline.
The granted patent strengthens Evelo Biosciences' intellectual property portfolio, which may attract more investors and lead to potential growth in the company's product pipeline. This positive development could result in a short-term increase in the stock price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100